Health Ministry prohibits manufacture or distribution for human use of 328 FDCs
The Drugs Technical Advisory Board recommended, amongst other things, that these FDCs may involve risk to human beings
Author
Green ChemisTree Foundation, GCIPR to organise technical conference
The objective of the conference is to enable greater business value for Indian pharma API and bulk intermediate manufacturers
Sun Pharma’s Mohali plant on FDA radar
Recently, the USFDA had issued Form 483 with six observations after an inspection of the company's Halol facility in Gujarat
Zydus Cadila gets tentative nod from USFDA for diabetes drug
The company has received tentative approval from the USFDA for Sitagliptin tablets in strengths of 25 mg, 50 mg, and 100 mg, Zydus…
Sun Pharma arm to acquire shares of Israeli firm Tarsius Pharma for $3 mn
Indicative time period for completion of the acquisition is before September 15, 2018, Sun Pharma said
National Insulin Summit draws over 300 Indian doctors to discuss innovations in insulin therapy
How early and appropriate use of insulin can not only prevent short-term complications, but also reduce long-term morbidity and…
India Tech Conclave to focus on possibilities enabled by AI & Automation
The conclave will look at various components that are essential to the making of a good manufacturing process enabled by AI and…
Consort, Opiant to develop nasal spray for opioid overdose treatment
California-based Opiant was awarded a grant by the US National Institutes of Health's National Institute on Drug Abuse for the…
Alembic Pharma board okays proposal to raise up to ₹300 cr via NCDs
The Board of Directors has also approved constituting an NCD Committee for issuance and allotment of NCDs
Glenmark secures marketing authorisation in Germany for generic version of Seretide Accuhaler
Glenmark has already launched its generic version of Seretide Accuhaler in Denmark, Sweden and Norway